| Primary |
| Atrial Fibrillation |
22.2% |
| Hypertension |
15.6% |
| Product Used For Unknown Indication |
12.6% |
| Drug Use For Unknown Indication |
7.4% |
| Arrhythmia |
5.9% |
| Coronary Artery Disease |
5.2% |
| Tachyarrhythmia |
3.7% |
| Ventricular Tachycardia |
3.7% |
| Pain |
3.0% |
| Prophylaxis |
3.0% |
| Spinal Osteoarthritis |
3.0% |
| Diabetic Cardiomyopathy |
2.2% |
| Hypothyroidism |
2.2% |
| Atrial Flutter |
1.5% |
| Atrial Tachycardia |
1.5% |
| Cardiac Failure |
1.5% |
| Cardiomyopathy |
1.5% |
| Gout |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Polyuria |
1.5% |
|
| Shock |
12.5% |
| Weight Decreased |
10.4% |
| Lung Disorder |
6.3% |
| Pulmonary Oedema |
6.3% |
| Tachycardia |
6.3% |
| Tubulointerstitial Nephritis |
6.3% |
| Hyperthyroidism |
4.2% |
| Hypothyroidism |
4.2% |
| Injection Site Vesicles |
4.2% |
| Interstitial Lung Disease |
4.2% |
| Lividity |
4.2% |
| Maculopathy |
4.2% |
| Muscle Contractions Involuntary |
4.2% |
| Nausea |
4.2% |
| Pharmaceutical Product Complaint |
4.2% |
| Pulmonary Hypertension |
4.2% |
| Retching |
4.2% |
| Ascites |
2.1% |
| Blood Creatine Phosphokinase Increased |
2.1% |
| Cardiac Arrest |
2.1% |
|
| Secondary |
| Hypertension |
22.9% |
| Drug Use For Unknown Indication |
12.4% |
| Atrial Fibrillation |
10.9% |
| Pain |
8.7% |
| Spinal Osteoarthritis |
5.8% |
| Coronary Artery Disease |
5.5% |
| Thrombosis Prophylaxis |
5.1% |
| Prophylaxis |
4.0% |
| Product Used For Unknown Indication |
3.3% |
| Rash |
3.3% |
| Renal Failure |
3.3% |
| Hyperlipidaemia |
2.2% |
| Intervertebral Discitis |
2.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.2% |
| Oedema |
1.8% |
| Tachyarrhythmia |
1.8% |
| Sleep Disorder |
1.5% |
| Arrhythmia |
1.1% |
| Diabetic Cardiomyopathy |
1.1% |
| Hyperuricaemia |
1.1% |
|
| Renal Failure Acute |
18.9% |
| Small Intestinal Perforation |
11.3% |
| Torsade De Pointes |
11.3% |
| Vomiting |
9.4% |
| Stevens-johnson Syndrome |
7.5% |
| Paraesthesia |
5.7% |
| Chest Pain |
3.8% |
| Lung Disorder |
3.8% |
| Retching |
3.8% |
| Swollen Tongue |
3.8% |
| Toxic Epidermal Necrolysis |
3.8% |
| Anaemia |
1.9% |
| Circulatory Collapse |
1.9% |
| Flatulence |
1.9% |
| Hepatic Failure |
1.9% |
| Hepatitis Acute |
1.9% |
| Hepatorenal Syndrome |
1.9% |
| Hypothyroidism |
1.9% |
| Injection Site Vesicles |
1.9% |
| Interstitial Lung Disease |
1.9% |
|
| Concomitant |
| Prophylaxis Against Renal Transplant Rejection |
24.7% |
| Product Used For Unknown Indication |
23.7% |
| Prophylaxis |
9.5% |
| Drug Use For Unknown Indication |
6.1% |
| Hypertension |
4.5% |
| Prophylaxis Against Transplant Rejection |
3.9% |
| Anaesthesia |
3.8% |
| Supplementation Therapy |
2.9% |
| Parenteral Nutrition |
2.8% |
| Infection |
2.2% |
| Pain |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Diabetes Mellitus |
2.1% |
| Bradycardia |
1.7% |
| Cardiac Failure |
1.7% |
| Atrial Fibrillation |
1.4% |
| Adenocarcinoma |
1.3% |
| Pain Prophylaxis |
1.3% |
| Infection Prophylaxis |
1.1% |
| Mineral Supplementation |
1.1% |
|
| Pyrexia |
10.0% |
| Wound Dehiscence |
8.0% |
| Meningitis Enterococcal |
6.0% |
| Pulmonary Embolism |
6.0% |
| Stevens-johnson Syndrome |
6.0% |
| Subcutaneous Abscess |
6.0% |
| Tachyarrhythmia |
6.0% |
| Toxic Epidermal Necrolysis |
6.0% |
| Ureteric Stenosis |
6.0% |
| Urinary Tract Infection |
6.0% |
| Vomiting |
6.0% |
| Acute Hepatic Failure |
4.0% |
| General Physical Health Deterioration |
4.0% |
| Staphylococcal Bacteraemia |
4.0% |
| Thermal Burn |
4.0% |
| Transferrin Saturation Decreased |
4.0% |
| Anaemia |
2.0% |
| Autoimmune Thrombocytopenia |
2.0% |
| Blood Glucose Increased |
2.0% |
| Cardiac Failure |
2.0% |
|
| Interacting |
| Hypertension |
27.3% |
| Pain |
18.2% |
| Atrial Fibrillation |
13.6% |
| Constipation |
4.5% |
| Gastrointestinal Stromal Tumour |
4.5% |
| Hyperlipidaemia |
4.5% |
| Intervertebral Discitis |
4.5% |
| Product Used For Unknown Indication |
4.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.5% |
| Restlessness |
4.5% |
| Sleep Disorder |
4.5% |
| Thrombosis Prophylaxis |
4.5% |
|
| Renal Failure Acute |
33.3% |
| Swollen Tongue |
33.3% |
| Unresponsive To Stimuli |
33.3% |
|
